We are live on ! Find out more
DWTX

Dogwood Therapeutics
DWTX

15 hedge funds and large institutions have $4.85M invested in Dogwood Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

15% more funds holding

Funds holding: 13 → 15 (+2)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.03% less ownership

Funds ownership: 0.48% → 0.46% (-0.03%)

9% less capital invested

Capital invested by funds: $5.3M → $4.85M (-$451K)

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$77K
2
BlackRock
BlackRock
New York
+$14.2K
3
UBS Group
UBS Group
Switzerland
+$11.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.9K
5
Simplex Trading
Simplex Trading
Illinois
+$890

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$152K
2
Two Sigma Investments
Two Sigma Investments
New York
-$94K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$70.7K
4
CA
Cetera Advisors
Colorado
-$63.2K
5
TRCT
Tower Research Capital (TRC)
New York
-$12.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
1
Masters Capital Management
Georgia
$3.33M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$757K – – –
CAPTRUST Financial Advisors
3
CAPTRUST Financial Advisors
North Carolina
$205K – – –
CA
4
Cetera Advisors
Colorado
$184K -$63.2K -497 -26%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$115K +$10.9K +86 +11%
BlackRock
6
BlackRock
New York
$95K +$14.2K +112 +18%
Northern Trust
7
Northern Trust
Illinois
$77K +$77K +605 New
Two Sigma Advisers
8
Two Sigma Advisers
New York
$74K -$70.7K -556 -49%
UBS Group
9
UBS Group
Switzerland
$12K +$11.4K +90 New
Osaic Holdings
10
Osaic Holdings
Arizona
$9K +$254 +2 +3%
TIM
11
Tevis Investment Management
Texas
$1K +$382 +3 New
Millennium Management
12
Millennium Management
New York
– -$152K -1,151 Closed
Two Sigma Investments
13
Two Sigma Investments
New York
– -$94K -711 Closed
TRCT
14
Tower Research Capital (TRC)
New York
– -$12.1K -95 -99%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
– -$5K -40 Closed
WWM
16
Wolff Wiese Magana
California
– +$254 +2 New
Simplex Trading
17
Simplex Trading
Illinois
– +$890 +7 New

DWTX Hedge Fund Activity: Q4 2021 in Review

15 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q4 2021, worth a combined $4.85M — down 8.5% from $5.3M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new DWTX positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Northern Trust, opening a new position worth an estimated $77K. The largest seller was Millennium Management, exiting entirely with an estimated $152K sold.

  • 15 institutional investors held Dogwood Therapeutics (DWTX) as of Q4 2021, up from 13 in Q3 2021.
  • Funds reported $4.85M of Dogwood Therapeutics stock for Q4 2021, down 8.5% quarter-over-quarter.
  • 5 funds opened new Dogwood Therapeutics positions in Q4 2021 and 3 closed out, a net change of +2 holders.
  • The largest Dogwood Therapeutics buyer in Q4 2021 was Northern Trust, an estimated $77K added.
  • The largest Dogwood Therapeutics seller in Q4 2021 was Millennium Management, an estimated $152K sold.

Based on aggregated 13F filings for Q4 2021.